Nootkatone attenuates airway inflammation in asthmatic mice through repressing ROS-induced NLRP3 inflammasome activation
Biochemistry and Cell Biology · 01.12.2023 · 101 (6) · 513-522
DOI: 10.1139/bcb-2023-0009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, erschienen am 01.12.2023. Verfasst von Yun Gai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Seventh People's Hospital of Shanghai University of TCM, Datong Road, Shanghai 200137, People's Republic of China. Hauptthemen laut MEDLINE: Inflammasomes, Asthma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Nootkatone (NKT) exhibits potential pharmacological activities including anti-oxidation and anti-inflammation. Nevertheless, little is known about the roles of NKT in asthmatic airway inflammation. In the study, mice were sensitized and challenged with ovalbumin (OVA) to establish experimental allergic asthma model. After treatment with NKT, lung tissues, peripheral blood, and bronchoalveolar lavage fluid (BALF) were collected to assess inflammatory cytokines, oxidative stress, and pathological alternations. The effects of NKT on regulating reactive oxygen species (ROS)-induced NLR family pyrin domain containing 3 (NLRP3) inflammasome activation was assessed in IL-13-treated BEAS-2B cell model. We found that NKT treatment decreased the production of Th2 inflammatory cytokines (IL-4, IL-5, and IL-13) in BALF and IgE levels in serum, and alleviated inflammatory cell penetration, goblet cell proliferation, collagen accumulation, and mucus hypersecretion in lung tissues. NKT treatment mitigated oxidative stress and NLRP3 inflammasome activation in asthmatic mice. IL-13 treatment induced oxidative stress and NLRP3-mediated pyroptosis in BEAS-2B bronchial epithelial cells, whereas these effects were blocked by NKT. NKT protected against airway remodeling, as indicated by decreased epithelial–mesenchymal transition. Taken together, these results demonstrate that NKT mitigates asthmatic airway inflammation by inhibiting ROS-triggered NLRP3 activation and may be a potential agent for treating asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Seventh People's Hospital of Shanghai University of TCM, Datong Road, Shanghai 200137, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, Changhai Hospital, Naval Medical University, Changhai Road, Shanghai 200433, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, Shu Guang Hospital of Shanghai University of TCM, Shanghai 201203, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Ningxia, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Xiahui Ge
Zitieren
APA
Gai, Y., Bai, C., Zhang, W., Xiao, H., Xu, J., Hou, J., & Ge, X. (2023). Nootkatone attenuates airway inflammation in asthmatic mice through repressing ROS-induced NLRP3 inflammasome activation. Biochemistry and Cell Biology, 101(6), 513-522. https://doi.org/10.1139/bcb-2023-0009
Vancouver
Gai Y, Bai C, Zhang W, Xiao H, Xu J, Hou J, et al. Nootkatone attenuates airway inflammation in asthmatic mice through repressing ROS-induced NLRP3 inflammasome activation. Biochemistry and Cell Biology. 2023;101(6):513-522. doi:10.1139/bcb-2023-0009
BibTeX
@article{Gai2023,
author = {Gai, Yun and Bai, Chong and Zhang, Wei and Xiao, Hua and Xu, Jing and Hou, Jia and Ge, Xiahui},
title = {Nootkatone attenuates airway inflammation in asthmatic mice through repressing ROS-induced NLRP3 inflammasome activation},
journal = {Biochemistry and Cell Biology},
year = {2023},
volume = {101},
number = {6},
pages = {513--522},
doi = {10.1139/bcb-2023-0009}
}
EUVIMED